A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

Recruiting now

Conditions studied: Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction

In brief

To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

Key facts

Study ID

NCT07093528

Run by

Mayo Clinic

People needed

25

Starts

2025-10-16

Expected to finish

2027-08-01

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18
• Enrollment in main CS-reducer HFPEF study IRB# 25-002292

You may not qualify if…

• Metal implants that are not suitable for MRI
• Inability or unwillingness of individual to give written informed consent.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.